03Nov 2023
Repurposing DPP4 Inhibition to Improve Hair Follicle Activation and Regeneration

Repurposing DPP4 Inhibition to Improve Hair Follicle Activation and Regeneration

Skin injuries and diseases often lead to fibrosis, causing hair follicle (HF) growth arrest and loss, impacting patients physically and psychologically. The study reveals elevated dipeptidyl peptidase 4 (DPP4) levels in areas with HF growth arrest and loss. Topical inhibition of DPP4 with sitagliptin in murine models accelerates HF activation/regeneration and reduces fibrosis markers in wounds. This FDA/European Medicines Agency-approved diabetes medication, when repurposed topically, holds promise for reversing alopecia and promoting HF regeneration after injury.

  • #dermatology

Like

Save

Share